As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of SUMMIT THERAPEUTICS INC COM - Stock (SMMT).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 0 | $0 | -$81,523 | 0 | |
| 2025 Q2 | 3,831 | $81,523 | +$50,630 | $21.28 | 12 |
| 2025 Q1 | 2,320 | $44,431 | -$161,205 | $19.29 | 10 |
| 2024 Q4 | 11,418 | $203,755 | +$187,963 | $17.84 | 7 |
| 2024 Q3 | 885 | $19,382 | +$417 | $21.90 | 2 |
| 2024 Q2 | 866 | $6,755 | +$2,558 | $7.80 | 2 |
| 2024 Q1 | 548 | $2,268 | -$28,509 | $4.12 | 2 |
| 2023 Q4 | 11,483 | $29,970 | -$665 | $2.61 | 2 |
| 2023 Q3 | 11,738 | $21,950 | -$90,673 | $1.87 | 2 |
| 2023 Q2 | 47,852 | $120,108 | -$8,711 | $2.51 | 4 |
| 2023 Q1 | 51,994 | $90,990 | +$81,319 | $1.75 | 6 |
| 2022 Q4 | 5,526 | $23,486 | -$10,764 | $4.25 | 4 |
| 2022 Q3 | 16,245 | $19,000 | +$2,435 | $1.16 | 3 |
| 2022 Q2 | 14,445 | $14,000 | +$192 | $1.00 | 3 |
| 2022 Q1 | 14,245 | $34,000 | +$5,000 | $2.49 | 3 |
| 2021 Q4 | 11,245 | $30,000 | -$3,000 | $2.67 | 1 |
| 2021 Q3 | 11,930 | $59,000 | -$5,756 | $4.74 | 3 |
| 2021 Q2 | 12,983 | $96,000 | +$9,263 | $7.01 | 4 |
| 2021 Q1 | 11,674 | $68,000 | -$240,570 | $5.70 | 3 |
| 2020 Q4 | 62,690 | $295,000 | -$30,000 | $4.73 | 5 |
| 2020 Q3 | 68,600 | $235,000 | -$24,104,008 | $3.42 | 3 |
| 2020 Q2 | 8,186,422 | $24,313,970 | -$659,821 | $2.97 | 18 |
| 2020 Q1 | 8,401,772 | $19,917,000 | +$13,659,867 | $2.37 | 10 |
| 2019 Q4 | 2,743,688 | $4,389,000 | +$131,027 | $1.60 | 11 |
| 2019 Q3 | 2,657,174 | $4,756,000 | -$8,606 | $1.79 | 10 |
| 2019 Q2 | 2,662,960 | $3,369,000 | +$56,120 | $1.27 | 8 |
| 2019 Q1 | 2,593,858 | $4,748,000 | -$216,604 | $1.83 | 11 |
| 2018 Q4 | 2,881,399 | $3,313,000 | -$171,212 | $1.15 | 8 |
| 2018 Q3 | 2,716,831 | $6,030,000 | -$1,187,761 | $2.22 | 11 |
| 2018 Q2 | 3,222,086 | $7,894,000 | -$8,096,673 | $2.45 | 13 |
| 2018 Q1 | 4,143,303 | $53,319,000 | +$2,089,366 | $12.90 | 19 |
| 2017 Q4 | 4,017,625 | $44,513,000 | -$755,139 | $11.08 | 20 |
| 2017 Q3 | 4,054,940 | $50,865,000 | +$17,110,037 | $12.55 | 20 |
| 2017 Q2 | 2,690,736 | $30,479,000 | -$62,231 | $11.33 | 14 |
| 2017 Q1 | 2,694,940 | $35,802,000 | -$9,122 | $13.28 | 15 |
| 2016 Q4 | 2,695,646 | $23,072,000 | -$269,384 | $8.56 | 11 |
| 2016 Q3 | 2,727,116 | $24,762,000 | -$66,243 | $9.06 | 12 |
| 2016 Q2 | 2,734,292 | $21,923,000 | -$365,239 | $7.91 | 10 |
| 2016 Q1 | 2,669,891 | $18,277,000 | -$323,117 | $6.82 | 8 |
| 2015 Q4 | 2,835,071 | $32,595,000 | -$36,517 | $11.50 | 10 |
| 2015 Q3 | 2,838,493 | $29,548,000 | +$990,258 | $10.41 | 10 |
| 2015 Q2 | 0 | $0 | -$1,724,002 | 0 | |
| 2015 Q1 | 2,680,373 | $33,209,000 | +$33,208,973 | $12.39 | 7 |